"Leukemia, Myeloid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Descriptor ID |
D007951
|
| MeSH Number(s) |
C04.557.337.539
|
| Concept/Terms |
Leukemia, Myeloid- Leukemia, Myeloid
- Leukemia, Granulocytic
- Myeloid Leukemia
- Leukemias, Myeloid
- Myeloid Leukemias
- Leukemia, Myelogenous
- Leukemias, Myelogenous
- Myelogenous Leukemias
- Myelocytic Leukemia
- Myelogenous Leukemia
- Granulocytic Leukemia
- Granulocytic Leukemias
- Leukemias, Granulocytic
- Leukemia, Myelocytic
- Leukemias, Myelocytic
- Myelocytic Leukemias
Leukemia, Monocytic, Chronic- Leukemia, Monocytic, Chronic
- Monocytic Leukemia, Chronic
- Chronic Monocytic Leukemia
- Chronic Monocytic Leukemias
- Leukemia, Chronic Monocytic
- Leukemias, Chronic Monocytic
- Monocytic Leukemias, Chronic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, Myeloid".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, Myeloid".
- Leukemia, Myeloid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Sarcoma, Myeloid
This graph shows the total number of publications written about "Leukemia, Myeloid" by people in this website by year, and whether "Leukemia, Myeloid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 7 | 2 | 9 |
| 1994 | 2 | 2 | 4 |
| 1995 | 4 | 0 | 4 |
| 1996 | 8 | 1 | 9 |
| 1997 | 6 | 2 | 8 |
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 8 | 1 | 9 |
| 2001 | 4 | 1 | 5 |
| 2002 | 12 | 2 | 14 |
| 2003 | 11 | 0 | 11 |
| 2004 | 10 | 1 | 11 |
| 2005 | 4 | 0 | 4 |
| 2006 | 9 | 1 | 10 |
| 2007 | 3 | 2 | 5 |
| 2008 | 3 | 0 | 3 |
| 2009 | 4 | 1 | 5 |
| 2010 | 3 | 2 | 5 |
| 2011 | 3 | 1 | 4 |
| 2012 | 4 | 0 | 4 |
| 2013 | 1 | 0 | 1 |
| 2014 | 3 | 2 | 5 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, Myeloid" by people in Profiles.
-
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation. Genes Chromosomes Cancer. 2022 02; 61(2):71-80.
-
Cytotoxic Therapy-Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms. Blood Cancer Discov. 2020 07; 1(1):32-47.
-
ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants. Blood Adv. 2019 10 22; 3(20):2962-2979.
-
Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms. Blood Adv. 2018 01 09; 2(1):36-48.
-
Clofarabine as a bridge to hematopoietic stem cell transplant. Leuk Lymphoma. 2017 01; 58(1):230-232.
-
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun. 2016 04 26; 7:11452.
-
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016 05 19; 127(20):2391-405.
-
The diagnostic and clinical impact of genetics and epigenetics in acute myeloid leukemia. Int J Lab Hematol. 2015 May; 37 Suppl 1:122-32.
-
Detecting differential patterns of interaction in molecular pathways. Biostatistics. 2015 Apr; 16(2):240-51.
-
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer Chemother Pharmacol. 2014 Nov; 74(5):927-38.